Notably, remote patient monitoring was one of the most frequently referenced themes in Q2 2023, ranking highest in terms of mentions, ahead of mobile and internet of things, according to GlobalData.

Of the top leading companies in the medical industry, Medtronic had the greatest increase in references for remote patient monitoring in Q2 2023, compared with the previous quarter. GlobalData identified 11 remote patient monitoring-related sentences in the company's filings - 2% of all sentences - and a decrease of 42% in Q2 2023 compared with Q2 2022. Baxter International’s mentions of remote patient monitoring rose by 100% to 4 and DexCom’s by 33% to 4 and Abbott Laboratories’s by 40% to 3.

GlobalData’s Company Filings Analytics also applies sentiment weight to reference sentences, based on whether the sentences are positive, negative, or neutral. Starting at 100 in 2020, an index over 100 is more positive. The overall index for remote patient monitoring in Q2 2023 was 106.

For further understanding of GlobalData's Remote Patient Monitoring Devices - Thematic Research buy the report here.

This content was updated on 5 August 2023

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Company Filings Analytics uses machine learning to uncover key insights and track sentiment across millions of regulatory filings and other corporate disclosures for thousands of companies across the world’s largest industries.